Effects of PPAR and RXR ligands in semaphorin 6B gene expression of human MCF-7 breast cancer cells

International Journal of Oncology

Volumn 28, Issue 4, 2006, Pages 977-984

  Murad, Hossam ^a   Collet, Philippe ^a   Huin Schohn, Cecile ^a   Al Makdissy, Nehmann ^a   Kerjan, Geraldine ^b   Chedotal, Alain ^b   Donner, Mireille ^a   Devignes, Marie Dominique ^c   Becuwe, Philippe ^a   Schohn, Herve ^a   Domenjoud, Lionel ^a   Dauça, Michel ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b Groupe Enzymologie Moléculaire et Fonctionnelle   (France)

^c LORIA   (France)

Author keywords

9 cis retinoic acid receptor; MCF 7 cells; Peroxisome proliferator; Peroxisome proliferator activated receptor; Semaphorin 6B; Semaphorins

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALITRETINOIN; CHROMAN DERIVATIVE; FENOFIBRATE; GW 610742; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOIC ACID; RETINOID X RECEPTOR; SEMA6B PROTEIN, HUMAN; SEMAPHORIN; THIAZOLE DERIVATIVE; TROGLITAZONE;

ARTICLE; BREAST TUMOR; CELL LINE; CELL STRAIN HT29; CELL STRAIN K 562; CHEMISTRY; DIMERIZATION; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CHROMANS; DIMERIZATION; GENE EXPRESSION; HT29 CELLS; HUMANS; K562 CELLS; PPAR ALPHA; PPAR DELTA; PPAR GAMMA; PROCETOFEN; RETINOID X RECEPTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEMAPHORINS; THIAZOLES; THIAZOLIDINEDIONES; TRETINOIN;

EID: 33744736310     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.4.977     Document Type: Article

References (49)

1. Kolodkin AL, Matthes DJ and Goodman CS: The semaphorin genes encode a family of transmembrane and secreted growth cone guidance. Cell 75: 1389-1399, 1993.
2. Luo Y, Raible D and Raper JA: Collapsin: a protein in the brain that induces the collapse and paralysis of neuronal growth cones. Cell 75: 217-227, 1993.
3. Tamagnone L and Comoglio PM: Signalling by semaphorin receptors: cell guidance and beyond. Biology 10: 377-383, 2000.
4. Goodman CS, Kolodkin AL, Luo Y, Pueschel AW and Raper JA: Unified nomenclature for the semaphorins collapsins. Cell 97: 551-552, 1999.
5. Raper JA: Semaphorins and their receptors in vertebrates and invertebrates. Curr Opin Neurobiol 10: 88-94, 2000.
6. Toyofuku T, Zhang, H, Kumanogoh A, Takegahara, N, Suto F, Kamei J, Aoki K, Yabuki M, Hori M, Fujisawa H and Kikutani H: Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-tackand vascular endothelial growth factor receptor type 2. Genes Dev 18: 435-447, 2004.
7. Klostermann A, Lutz B, Gertler F and Behl C: The orthologous human and murine semaphorin 6A-1 proteins (SEMA6A-1/Sema6A-1) bind to the enabled/vasodilator-stimulated phosphoprotein-like protein (EVL) via a novel carboxyl-terminal zyxin-like domain. J Biol Chem 275: 39647-39653, 2000.
8. Eckhardt F, Behar O, Calautti E, Yonezawa K, Nishimoto I and Fishman MC: A novel transmembrane semaphorin can bind c-src. Mol Cell Neurosci 9: 409-419, 1997.
9. Collet P, Domenjoud L, Devignes MD, Murad H, Schohn HA and Dauca M: The human semaphorin 6B gene is down-regulated by PPARs. Genomics 83: 1141-1150, 2004.
10. Escher P and Wahli W: Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res 448: 121-138, 2000.
11. Kliewer SA, Umesono K, Noonan DJ, Heyman RA and Evans RM: Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358: 771-774, 1992.
12. Stein GH: T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. Cell 99: 43-54, 1979.
13. Beckman G, Beckman L, Ponten J and Westermark B: -6-PD and PGM phenotypes of 16 continuous human lines. Evidence against cross-contamination and contamination by HeLa cells. Hum Hered 21: 238-241, 1971.
14. Biedler JL, Roffler-Tarlov S, Schachner M and Freedman LS: Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38: 3751-3757, 1978.
15. Knowles BB, Howe CC and Aden DP: Human hepatocellular carcinoma cell lines secrete the plasma proteins and hepatitis B surface antigen. Science 209: 497-499, 1980.
16. Pfeifer AM, Cole KE, Smoot DT, Weston A, Groopman JD, Shields PG, Vignaud JM, Juillerat M, Lipsky MM and Trump BF: Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc Natl Acad Sci USA 90: 5123-5127, 1993.
17. Fogh J and Trempe G: Human Tumor Cells In Vitro. Fogh J (ed). pp115-141, 1975.
18. Brattain MG, Fine WD, Khaled FM, Thompson J and Brattain DE: Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res 41: 1751-1756, 1981.
19. Jacobs JP, Jones CM and Baille JP: Characteristics of a human diploid cell designated MRC-5. Nature 227: 168-170, 1970.
20. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H and Park WP: In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51: 1417-1423, 1973.
21. Graham FL, Smiley J, Russell WC and Nairn R: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74, 1977.
22. Brooks SC, Locke ER and Soule HD: Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem 248: 6251-6253, 1973.
23. Lozzio CB and Lozzio BB: Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45: 312-334, 1975.
24. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
25. Correa RG, Sasahara RM, Bengtson MH, Katayama MLH, Salim ACM, Brentani MM, Sogayar MC, De Souza SJ and Simpson AJG: Human semaphorin 6B [(HSA)SEMA6B], a novel human class 6 semaphorin gene: alternative splicing and all-trans-retinoic acid-dependent down-regulation in glioblastoma cell lines. Genomics 73: 343-348, 2001.
26. Hanauer A and Mandel JL: The glyceraldehyde 3 phosphate dehydrogenase gene family: structure of a human cDNA and of an X chromosome linked pseudogene; amazing complexity of the gene family in mouse. EMBO J 3: 2627-2633, 1984.
27. Gobin S, Bonnefont JP, Prip-Buus C, Mugnier C, Ferrec M, Demaugre F, Saudubray JM, Rostane H, Djouadi F, Wilcox W, Cederbaum S, Haas R, Nyhan WL, Green A, Gray G, Girard J and Thuillier L: Organization of the human liver carnitine palmitoyltransferase 1 gene (CPT1A) and identification of novel mutations in hypoketotic hypoglycaemia. Human Genet 111: 179-189, 2002.
28. Louet JF, Le May C, Pegorier JP, Decaux JF and Girard J: Regulation of liver carnitine palmitoyltransferase I gene expression by hormones and fatty acids. Biochem Soc Trans 29: 310-316, 2001.
29. Kikuchi K, Ishida H and Kimura T: Molecular cloning of a novel member of semaphorin family genes, semaphorin Z. Brain Res Mol Brain Res 51: 229-237, 1997.
30. Plénat F, Martinet Y, Martinet N and Vignaud JM: Immunohistochemical methods for studying mononuclear phagocytes in tissue sections. J Immunol Methods 174: 133-154, 1994.
31. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
32. Roche J, Boldog F, Robinson M, Robinson L, Varella-Garcia M, Swanton M, Waggoner B, Fishel R, Franklin W, Gemmill R and Drabkin H: Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene 12: 1289-1297, 1996.
33. Roche J and Drabkin HA: The role of semaphorins in lung cancer. Clin Lung Cancer 3: 145-150, 2001.
34. Neufeld G, Shraga-Heled N, Lange T, Guttmann-Raviv N, Herzog Y and Kessler O: Semaphorins in cancer. Front Biosci 10: 751-760, 2005.
35. Sekido Y, Bader S, Latif F, Chen JY, Duh FM, Wei MH, Albanesi JP, Lee CC, Lerman MI and Minna JD: Human semaphorin A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci USA 93: 4120-4125, 1996.
36. Nassare P, Constantin B, Rouhaud L, Harnois T, Raymond G, Drabkin HA, Bourmeyster N and Roche J: Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading. Neoplasia 5: 83-92, 2003.
37. Serini G, Valdembri D, Zanivan S, Morterra G, Burkhardt C, Caccavari F, Zammataro L, Primo L, Tamagnone L, Logan M, Tessier-Lavigne M, Taniguchi M, Puschel AW and Bussolino F: Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 424: 391-397, 2003.
38. Bates D, Taylor GI, Minichiello J, Farlie P, Cichowitz A, Watson N, Klagsbrun M, Mamluk R and Newgreen DF: Neurovascular congruence results from a shared patterning mechanism that utilizes Semaphorin3A and Neuropilin-1. Dev Biol 225: 77-98, 2003.
39. Kessler O, Shraga-Heled N, Lange T, Gutmann-Raviv N, Sabo E, Baruch L, Machluf M and Neufeld G: Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res 64: 1008-1015, 2004.
40. Yamada T, Endo R, Gotoh M and Hirohashi S: Identification of semaphorin E as a non-MDR drug resistance gene of human cancers. Proc Natl Acad Sci USA 94: 14713-14718, 1997.
41. Martin-Satue M and Blanco J: Identification of semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA differential display. J Surg Oncol 72: 18-23, 1999.
42. Rieger J, Wick W and Weller M: Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. GLIA 42: 379-389, 2003.
43. Christensen CR, Klingelhofer J, Tarabykina S, Hulgaard EF, Kramerov D and Lukanidin E: Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Res 58: 1238-1244, 1998.
44. Giordano S, Corso S, Conrotto P, Artigiani S, Gilestro G, Barberis D, Tamagnone L and Comoglio PM: The semaphorin 4D receptor controls invasive growth by coupling with Met Nat. Cell Biol 4: 720-724, 2002.
45. Artigiani S, Conrotto P, Fazzari P, Gilestro GF, Barberis D, Giordano S, Comoglio PM and Tamagnone L: Plexin-B3 is a functional receptor for semaphorin 5A. EMBO Rep 5: 710-714, 2004.
46. Xu XM, Fisher DA, Zhou L, White FA, Ng S, Snider WD and Luo Y: The transmembrane protein semaphorin 6A repels embryonic sympathetic axons. J Neurosci 20: 2638-2648, 2000.
47. Qu X, Wei H, Zhai Y, Que H, Chen Q, Tang F, Wu Y, Xing G, Zhu Y, Liu S, Fan M and He F: Identification, characterization and functional study of the two novel human members of the semaphorin gene family. J Biol Chem 277: 35574-35585, 2002.
48. Suto F, Ito K, Uemara M, Shimizu M, Shinkawa Y, Sanbo M, Shinoda T, Tsuboi M, Takashima S, Yagi T and Fujisawa H: Plexin-a4 mediates axon-repulsive activities of both secreted and transmembrane semaphorins and plays roles in nerve fiber guidance. J Neurosci 6: 3628-3637, 2005.
49. Toyofuku T, Zhang H, Kumanogoh A, Takegahara N, Yabuki M, Harada K, Hori M and Kikutanu H: Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling. Nat Cell Biol 6: 1204-1211, 2004.